XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Balance Sheets - USD ($)
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 1,449,795 $ 2,959
Other receivables 12,222
Assets held for sale (Note 6) 28,703
Total current assets 1,478,498 15,181
Restricted cash 59
Fixed assets, net of accumulated depreciation of $26,120 at December 31, 2017 14,290
Total assets 1,478,498 29,530
Current liabilities:    
Accounts payable and accrued liabilities 206,304 445,653
Accounts payable - related party 82,331
Deferred revenues 50,000
Employee payable 16,667 98,476
Accrued interest payable (Note 3) 1,922 67,846
Short term portion of convertible notes (Note 3) 186,412 317,635
Liabilities held for sale (Note 6) [1] 459,965
Total current liabilities 921,270 1,011,941
Convertible notes (Note 3) 606,165
Total liabilities 21,999,798 1,618,106
Stockholders' deficit    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none and 529 Series A shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively. [1]
Common stock, $0.0001 par value; 490,000,000 shares authorized; 22,543,008 and 59,205,162 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively. (Note 4) 5,821 2,255
Accumulated other comprehensive income (19,337) (19,337)
Additional paid-in capital (Note 4) 37,876,289 14,968,925
Receipt on account of shares (Note 4) 117,150 80,000
Accumulated deficit (37,422,795) (16,620,419)
Total stockholders' equity (deficit) 557,227 (1,588,576)
Total liabilities and stockholders' equity (deficit) $ 1,478,497 $ 29,530
[1] Includes $82.331 payable to a related party.